GL1X · GenesisL1 explorer

Research workbench

Structure of a type III CRISPR defence DNA nuclease activated by cyclic oligoadenylate

Analyse Structure of a type III CRISPR defence DNA nuclease activated by cyclic… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6SCE
Type
protein + RNA
Length
618 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Uncharacterized protein; Cyclic oligoadenylate
UniProt
Q53W14
Pockets
6 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 39% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUncharacterized proteinprotein61439% helix, 24% strandQ53W14
BCyclic oligoadenylaterna4——

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110050.830.8477empty
2780.580.8819empty
3660.370.7813empty
4630.370.7914empty
5700.320.7519empty

Interfaces

1 interface between chains.

  • A–B · 1058 Ų buried · 36 hydrogen bonds · protein-nucleic

Modifications

Observed in the structure: 7 modified (engineered).

Compared structures

  • 6SCE · Structure of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylate · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.